Carregant...
FLT3 inhibitor design using molecular docking based virtual screening for acute myeloid leukemia
Acute Myeloid Leukaemia (AML) is a blood cancer, which affects the red blood cells in the bone marrow. Of the possible proteins that are affected in AML, fms-like tyrosine kinase 3 (FLT3) has long been recognized as a potential therapeutic target as it affects the other signaling pathways and leads...
Guardat en:
| Publicat a: | Bioinformation |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Biomedical Informatics
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6677903/ https://ncbi.nlm.nih.gov/pubmed/31435156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6026/97320630015104 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|